REFERENCES
1. Zeng Z, Zhan J, Zhang K, Chen H, Cheng S. Global, regional, and national burden of urinary tract infections from 1990 to 2019: an analysis of the global burden of disease study 2019. World J Urol. 2022;40:755-63.
2. National Health Service. Urinary tract infections (UTIs). Available from: https://www.nhs.uk/conditions/urinary-tract-infections-utis/. [Last accessed on 12 Nov 2025].
3. Pietrucha-Dilanchian P, Hooton TM. Diagnosis, treatment, and prevention of urinary tract infection. Microbiol Spectr. 2016;4:10.1128/microbiolspec.uti-0021-2015.
4. Osamwonyi B, Foley C. Management of recurrent urinary tract infections in adults. Surgery. 2017;35:299-305.
5. Rana DS, Sharma V, Sheershwal A. Understanding host-pathogen interactions in urinary tract infections and advancements in diagnostic methods. Urol Sci. 2025;36:61-75.
6. Klein RD, Hultgren SJ. Urinary tract infections: microbial pathogenesis, host-pathogen interactions and new treatment strategies. Nat Rev Microbiol. 2020;18:211-26.
7. Idrees MM, Saeed A. Genetic and molecular mechanisms of multidrug-resistance in uropathogens and novel therapeutic combat. In: Ahmed S, Chandra Ojha S, Najam-ul-haq M, Younus M, Hashmi MZ, Editors. Biochemistry of drug resistance. Cham: Springer International Publishing; 2021. pp. 505-38.
8. Zalewska-Piątek B, Olszewski M, Lipniacki T, et al. A shear stress micromodel of urinary tract infection by the Escherichia coli producing Dr adhesin. PLoS Pathog. 2020;16:e1008247.
9. La Bella AA, Andersen MJ, Gervais NC, et al. The catheterized bladder environment promotes Efg1- and Als1-dependent Candida albicans infection. Sci Adv. 2023;9:eade7689.
10. Werneburg GT. Catheter-associated urinary tract infections: current challenges and future prospects. Res Rep Urol. 2022;14:109-33.
12. Nett JE, Brooks EG, Cabezas-Olcoz J, et al. Rat indwelling urinary catheter model of Candida albicans biofilm infection. Infect Immun. 2014;82:4931-40.
13. Tomasek K, Leithner A, Glatzova I, Lukesch MS, Guet CC, Sixt M. Type 1 piliated uropathogenic Escherichia coli hijack the host immune response by binding to CD14. Elife. 2022;11:e78995.
14. Martínez-López R, Hernáez ML, Redondo E, et al. Candida albicans hyphal extracellular vesicles are different from yeast ones, carrying an active proteasome complex and showing a different role in host immune response. Microbiol Spectr. 2022;10:e0069822.
15. Huang Y, Li S, Teng Y, et al. Glucuronoxylomannan (GXM) modulates macrophage proliferation and apoptosis through the STAT1 signaling pathway. Cell Biol Int. 2025;49:317-28.
16. Yauch LE, Lam JS, Levitz SM. Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan. PLoS Pathog. 2006;2:e120.
17. Rodrigues ML, Nakayasu ES, Oliveira DL, et al. Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence. Eukaryot Cell. 2008;7:58-67.
18. Kouokam JC, Wai SN, Fällman M, et al. Active cytotoxic necrotizing factor 1 associated with outer membrane vesicles from uropathogenic Escherichia coli. Infect Immun. 2006;74:2022-30.
19. Yang H, Li Q, Wang C, et al. Cytotoxic necrotizing factor 1 downregulates CD36 transcription in macrophages to induce inflammation during acute urinary tract infections. Front Immunol. 2018;9:1987.
20. Pang Y, Cheng Z, Zhang S, et al. Bladder epithelial cell phosphate transporter inhibition protects mice against uropathogenic Escherichia coli infection. Cell Rep. 2022;39:110698.
21. Coady A, Ramos AR, Olson J, Nizet V, Patras KA. Tamm-horsfall protein protects the urinary tract against Candida albicans. Infect Immun. 2018;86:e00451-18.
22. Ponde NO, Lortal L, Ramage G, Naglik JR, Richardson JP.
23. Derakhshan S, Ahmadi S, Ahmadi E, Nasseri S, Aghaei A. Characterization of Escherichia coli isolated from urinary tract infection and association between virulence expression and antimicrobial susceptibility. BMC Microbiol. 2022;22:89.
24. Timm MR, Russell SK, Hultgren SJ. Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics. Nat Rev Microbiol. 2025;23:72-86.
25. Nhu NTK, Ravi C, Schembri MA. Uropathogenic Escherichia coli biofilms. Microbiol Aust. 2023;44:109-12.
26. Uppuluri P, Chaturvedi AK, Srinivasan A, et al. Dispersion as an important step in the Candida albicans biofilm developmental cycle. PLoS Pathog. 2010;6:e1000828.
27. González MJ, Navarro N, Cruz E, et al. First report on the physicochemical and proteomic characterization of Proteus mirabilis outer membrane vesicles under urine-mimicking growth conditions: comparative analysis with Escherichia coli. Front Microbiol. 2024;15:1493859.
28. Bitencourt TA, Hatanaka O, Pessoni AM, et al. Fungal extracellular vesicles are involved in intraspecies intracellular communication. mBio. 2022;13:e03272-21.
29. Liu L, Law COK, Nie Q, et al. Comparative analysis of outer membrane vesicles from uropathogenic Escherichia coli reveal the role of aromatic amino acids synthesis proteins in motility. Int J Med Microbiol. 2023;313:151573.
30. Zarnowski R, Sanchez H, Covelli AS, et al.
31. Taff HT, Nett JE, Zarnowski R, et al. A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance. PLoS Pathog. 2012;8:e1002848.
32. Zarnowski R, Noll A, Chevrette MG, et al. Coordination of fungal biofilm development by extracellular vesicle cargo. Nat Commun. 2021;12:6235.
33. Hong J, Dauros-Singorenko P, Whitcombe A, et al. Analysis of the Escherichia coli extracellular vesicle proteome identifies markers of purity and culture conditions. J Extracell Vesicles. 2019;8:1632099.
34. Fisher JF, Sobel JD, Kauffman CA, Newman CA.
35. Kramer CV, Zhang F, Sinclair D, Olliaro PL. Drugs for treating urinary schistosomiasis. Cochrane Database Syst Rev. 2014;2014:CD000053.
36. Gorczynska E, Turkiewicz D, Rybka K, et al. Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2005;11:797-804.
37. Ahmed SS, Shariq A, Alsalloom AA, Babikir IH, Alhomoud BN. Uropathogens and their antimicrobial resistance patterns: relationship with urinary tract infections. Int J Health Sci. 2019;13:48-55.
38. Belete MA, Saravanan M. A systematic review on drug resistant urinary tract infection among pregnant women in developing countries in Africa and Asia; 2005-2016. Infect Drug Resist. 2020;13:1465-77.
39. Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:eaau6977.
40. Martínez-López R, Hernáez ML, Redondo E, et al.
41. Colombo M, Moita C, van Niel G, et al. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci. 2013;126:5553-65.
42. Liu J, Hu X. Fungal extracellular vesicle-mediated regulation: from virulence factor to clinical application. Front Microbiol. 2023;14:1205477.
44. Tofiño-Vian M, Guillén MI, Pérez Del Caz MD, Silvestre A, Alcaraz MJ. Microvesicles from human adipose tissue-derived mesenchymal stem cells as a new protective strategy in osteoarthritic chondrocytes. Cell Physiol Biochem. 2018;47:11-25.
45. Fang Y, Wang Z, Liu X, Tyler BM. Biogenesis and biological functions of extracellular vesicles in cellular and organismal communication with microbes. Front Microbiol. 2022;13:817844.
46. Colombo M, Raposo G, Théry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255-89.
47. Hanson PI, Cashikar A. Multivesicular body morphogenesis. Annu Rev Cell Dev Biol. 2012;28:337-62.
48. Amabebe E, Kumar A, Tatiparthy M, Kammala AK, Taylor BD, Menon R. Cargo exchange between human and bacterial extracellular vesicles in gestational tissues: a new paradigm in communication and immune development. Extracell Vesicles Circ Nucl Acids. 2024;5:297-328.
49. Baeza N, Delgado L, Comas J, Mercade E. Phage-mediated explosive cell lysis induces the formation of a different type of O-IMV in Shewanella vesiculosa M7(T). Front Microbiol. 2021;12:713669.
50. Toyofuku M, Nomura N, Eberl L. Types and origins of bacterial membrane vesicles. Nat Rev Microbiol. 2019;17:13-24.
51. Turnbull L, Toyofuku M, Hynen AL, et al. Explosive cell lysis as a mechanism for the biogenesis of bacterial membrane vesicles and biofilms. Nat Commun. 2016;7:11220.
52. Briaud P, Carroll RK. Extracellular vesicle biogenesis and functions in gram-positive bacteria. Infect Immun. 2020;88:e00433-20.
53. Albino D, Falcione M, Uboldi V, et al. Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer. Commun Biol. 2021;4:119.
54. Kumar MA, Baba SK, Sadida HQ, et al. Extracellular vesicles as tools and targets in therapy for diseases. Signal Transduct Target Ther. 2024;9:27.
55. Hazrati A, Soudi S, Malekpour K, et al. Immune cells-derived exosomes function as a double-edged sword: role in disease progression and their therapeutic applications. Biomark Res. 2022;10:30.
56. Jan AT. Outer membrane vesicles (OMVs) of gram-negative bacteria: a perspective update. Front Microbiol. 2017;8:1053.
57. Lai Y, Jiang B, Hou F, et al. The emerging role of extracellular vesicles in fungi: a double-edged sword. Front Microbiol. 2023;14:1216895.
58. Bos J, Cisneros LH, Mazel D. Real-time tracking of bacterial membrane vesicles reveals enhanced membrane traffic upon antibiotic exposure. Science Advances. 2021;7:eabd1033.
59. Kwaku GN, Jensen KN, Simaku P, et al. Extracellular vesicles from diverse fungal pathogens induce species-specific and endocytosis-dependent immunomodulation. PLoS Pathog. 2025;21:e1012879.
60. Eitan E, Green J, Bodogai M, et al. Age-related changes in plasma extracellular vesicle characteristics and internalization by leukocytes. Sci Rep. 2017;7:1342.
61. Ekström K, Crescitelli R, Pétursson HI, Johansson J, Lässer C, Olofsson Bagge R. Characterization of surface markers on extracellular vesicles isolated from lymphatic exudate from patients with breast cancer. BMC Cancer. 2022;22:50.
62. Hoyer LL, Cota E.
63. Spencer N, Yeruva L. Role of bacterial infections in extracellular vesicles release and impact on immune response. Biomed J. 2021;44:157-64.
64. Chen N, Li Y, Liang X, et al. Bacterial extracellular vesicle: a non-negligible component in biofilm life cycle and challenges in biofilm treatments. Biofilm. 2024;8:100216.
65. Chan W, Chow FW, Tsang CC, et al. Induction of amphotericin B resistance in susceptible Candida auris by extracellular vesicles. Emerg Microbes Infect. 2022;11:1900-9.
66. Wang Z, Jiang Z, Zhang Y, et al. Exosomes derived from bladder epithelial cells infected with uropathogenic Escherichia coli increase the severity of urinary tract infections (UTIs) by impairing macrophage function. PLoS Pathog. 2024;20:e1011926.
67. Farajnia S, Alikhani MY, Ghotaslou R, Naghili B, Nakhlband A. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran. Int J Infect Dis. 2009;13:140-4.
69. Soto SM. Importance of biofilms in urinary tract infections: new therapeutic approaches. Advances in Biology. 2014;2014:1-13.
70. Schulze A, Mitterer F, Pombo JP, Schild S. Biofilms by bacterial human pathogens: clinical relevance - development, composition and regulation - therapeutical strategies. Microb Cell. 2021;8:28-56.
71. Amikam D, Galperin MY. PilZ domain is part of the bacterial c-di-GMP binding protein. Bioinformatics. 2006;22:3-6.
72. Han Q, Wang SF, Qian XX, et al. Flagellar brake protein YcgR interacts with motor proteins MotA and FliG to regulate the flagellar rotation speed and direction. Front Microbiol. 2023;14:1159974.
73. Jackson DW, Suzuki K, OakfordL
74. Khan F, Tabassum N, Pham DTN, Oloketuyi SF, Kim YM. Molecules involved in motility regulation in Escherichia coli cells: a review. Biofouling. 2020;36:889-908.
75. Hu XM, Peng L, Wu J, Wu G, Liang X, Yang JL. Bacterial c-di-GMP signaling gene affects mussel larval metamorphosis through outer membrane vesicles and lipopolysaccharides. NPJ Biofilms Microbiomes. 2024;10:38.
76. Baba T, Ara T, Hasegawa M, et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol. 2006;2:2006.0008.
77. Rocha SP, Pelayo JS, Elias WP. Fimbriae of uropathogenic Proteus mirabilis. FEMS Immunol Med Microbiol. 2007;51:1-7.
78. Rózalski A, Sidorczyk Z, Kotełko K. Potential virulence factors of Proteus bacilli. Microbiol Mol Biol Rev. 1997;61:65-89.
79. Coker C, Poore CA, Li X, Mobley HL. Pathogenesis of Proteus mirabilis urinary tract infection. Microbes Infect. 2000;2:1497-505.
80. Mey AR, Gómez-Garzón C, Payne SM. Iron transport and metabolism in Escherichia, Shigella, and Salmonella. EcoSal Plus. 2021;9:eESP-0034.
81. Klebba PE, Newton SMC, Six DA, et al. Iron acquisition systems of gram-negative bacterial pathogens define TonB-dependent pathways to novel antibiotics. Chem Rev. 2021;121:5193-239.
83. Sun Y, Wang X, Gong Q, et al. Extraintestinal pathogenic Escherichia coli utilizes surface-located elongation factor G to acquire iron from holo-transferrin. Microbiol Spectr. 2022;10:e01662-21.
84. Wiles TJ, Kulesus RR, Mulvey MA. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp Mol Pathol. 2008;85:11-9.
85. Subashchandrabose S, Hazen TH, Brumbaugh AR, et al. Host-specific induction of Escherichia coli fitness genes during human urinary tract infection. Proc Natl Acad Sci U S A. 2014;111:18327-32.
86. Subashchandrabose S, Mobley HL. Back to the metal age: battle for metals at the host-pathogen interface during urinary tract infection. Metallomics. 2015;7:935-42.
87. Kadurugamuwa JL, Beveridge TJ. Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion. J Bacteriol. 1995;177:3998-4008.
88. Smith YC, Rasmussen SB, Grande KK, Conran RM, O’Brien AD. Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice. Infect Immun. 2008;76:2978-90.
89. Nakatsuji S, Okumura K, Takase R, Watanabe D, Mikami B, Hashimoto W. Crystal structures of EfeB and EfeO in a bacterial siderophore-independent iron transport system. Biochem Biophys Res Commun. 2022;594:124-30.
90. Papareddy P, Tapken I, Kroh K, et al. The role of extracellular vesicle fusion with target cells in triggering systemic inflammation. Nat Commun. 2024;15:1150.
91. Banerjee S, Chanakira MN, Hall J, Kerkan A, Dasgupta S, Martin DW. A review on bacterial redox dependent iron transporters and their evolutionary relationship. J Inorg Biochem. 2022;229:111721.
92. Miethke M, Monteferrante CG, Marahiel MA, van Dijl JM. The Bacillus subtilis EfeUOB transporter is essential for high-affinity acquisition of ferrous and ferric iron. Biochim Biophys Acta. 2013;1833:2267-78.
93. Dadi BR, Abebe T, Zhang L, Mihret A, Abebe W, Amogne W. Distribution of virulence genes and phylogenetics of uropathogenic Escherichia coli among urinary tract infection patients in Addis Ababa, Ethiopia. BMC Infect Dis. 2020;20:108.
94. Deo P, Chow SH, Han ML, et al. Mitochondrial dysfunction caused by outer membrane vesicles from Gram-negative bacteria activates intrinsic apoptosis and inflammation. Nat Microbiol. 2020;5:1418-27.
95. Zhao G, Jones MK. Role of bacterial extracellular vesicles in manipulating infection. Infect Immun. 2023;91:e0043922.
96. Chen S, Lei Q, Zou X, Ma D. The role and mechanisms of gram-negative bacterial outer membrane vesicles in inflammatory diseases. Front Immunol. 2023;14:1157813.
97. Yang J, Hwang I, Lee E, et al. Bacterial outer membrane vesicle-mediated cytosolic delivery of flagellin triggers host NLRC4 canonical inflammasome signaling. Front Immunol. 2020;11:581165.
98. Vanaja SK, Russo AJ, Behl B, et al. Bacterial outer membrane vesicles mediate cytosolic localization of LPS and caspase-11 activation. Cell. 2016;165:1106-19.
99. Yao L, Wei B, Wang Y, et al. A critical role of outer membrane vesicles in antibiotic resistance in carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2023;22:95.
100. Li P, Luo W, Xiang TX, et al. Horizontal gene transfer via OMVs co-carrying virulence and antimicrobial-resistant genes is a novel way for the dissemination of carbapenem-resistant hypervirulent Klebsiella pneumoniae. Front Microbiol. 2022;13:945972.
101. Wagner T, Joshi B, Janice J, et al. Enterococcus faecium produces membrane vesicles containing virulence factors and antimicrobial resistance related proteins. J Proteomics. 2018;187:28-38.
102. Fisher JF, Kavanagh K, Sobel JD, Kauffman CA, Newman CA. Candida urinary tract infection: pathogenesis. Clin Infect Dis. 2011;52:S437-51.
103. Fisher JF. Candida urinary tract infections--epidemiology, pathogenesis, diagnosis, and treatment: executive summary. Clin Infect Dis. 2011;52:S429-32.
104. Goetz LL, Howard M, Cipher D, Revankar SG. Occurrence of candiduria in a population of chronically catheterized patients with spinal cord injury. Spinal Cord. 2010;48:51-4.
105. Nett JE, Sanchez H, Cain MT, Andes DR. Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan. J Infect Dis. 2010;202:171-5.
106. Nett JE, Andes DR. Fungal biofilms: in vivo models for discovery of anti-biofilm drugs. Microbiology Spectrum. 2015;3:10.1128/microbiolspec.mb-0008-2014.
107. Sandini S, La Valle R, De Bernardis F, Macrì C, Cassone A. The 65 kDa mannoprotein gene of Candida albicans encodes a putative beta-glucanase adhesin required for hyphal morphogenesis and experimental pathogenicity. Cell Microbiol. 2007;9:1223-38.
108. Karkowska-Kuleta J, Kulig K, Karnas E, et al. Characteristics of extracellular vesicles released by the pathogenic yeast-like fungi Candida glabrata, Candida parapsilosis and Candida tropicalis. Cells. 2020;9:1722.
109. Slettengren M, Mohanty S, Kamolvit W, van der Linden J, Brauner A. Making medical devices safer: impact of plastic and silicone oil on microbial biofilm formation. J Hosp Infect. 2020;106:155-62.
110. Hudson DA, Sciascia QL, Sanders RJ, et al. Identification of the dialysable serum inducer of germ-tube formation in Candida albicans. Microbiology. 2004;150:3041-9.
111. Feng Q, Summers E, Guo B, Fink G. Ras signaling is required for serum-induced hyphal differentiation in Candida albicans. J Bacteriol. 1999;181:6339-46.
112. Hornby JM, Jensen EC, Lisec AD, et al. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl Environ Microbiol. 2001;67:2982-92.
113. McCreath KJ, Specht CA, Robbins PW. Molecular cloning and characterization of chitinase genes from Candida albicans. Proc Natl Acad Sci U S A. 1995;92:2544-8.
114. Honorato L, de Araujo JFD, Ellis CC, et al. Extracellular vesicles regulate biofilm formation and yeast-to-hypha differentiation in Candida albicans. mBio. 2022;13:e0030122.
115. Jothi R, Hari Prasath N, Gowrishankar S, Pandian SK. Bacterial quorum-sensing molecules as promising natural inhibitors of Candida albicans virulence dimorphism: an in silico and in vitro study. Front Cell Infect Microbiol. 2021;11:781790.
116. Davis-Hanna A, Piispanen AE, Stateva LI, Hogan DA. Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis. Mol Microbiol. 2008;67:47-62.
117. Karkowska-Kuleta J, Kulig K, Bras G, et al.
118. Ibrahim AS, Filler SG, Sanglard D, Edwards JE, Hube B. Secreted aspartyl proteinases and interactions of Candida albicans with human endothelial cells. Infect Immun. 1998;66:3003-5.
119. Chen YT, Lin CY, Tsai PW, Yang CY, Hsieh WP, Lan CY. Rhb1 regulates the expression of secreted aspartic protease 2 through the TOR signaling pathway in Candida albicans. Eukaryot Cell. 2012;11:168-82.
120. Zamith-Miranda D, Heyman HM, Couvillion SP, et al. Comparative molecular and immunoregulatory analysis of extracellular vesicles from Candida albicans and Candida auris. mSystems. 2021;6:e0082221.
121. Vargas G, Rocha JD, Oliveira DL, et al. Compositional and immunobiological analyses of extracellular vesicles released by Candida albicans. Cell Microbiol. 2015;17:389-407.
122. Zawrotniak M, Satala D, Juszczak M, Bras G, Rapala-Kozik M. Candida albicans aspartyl protease (Sap6) inhibits neutrophil function via a “Trojan horse” mechanism. Sci Rep. 2025;15:6946.
123. Brown Harding H, Kwaku GN, Reardon CM, et al. Candida albicans extracellular vesicles trigger type I IFN signalling via cGAS and STING. Nat Microbiol. 2024;9:95-107.
124. Chen T, Feng Y, Sun W, et al. The nucleotide receptor STING translocates to the phagosomes to negatively regulate anti-fungal immunity. Immunity. 2023;56:1727-42.e6.
125. Cheng Z, Dai T, He X, et al. The interactions between cGAS-STING pathway and pathogens. Signal Transduct Target Ther. 2020;5:91.
126. Decout A, Katz JD, Venkatraman S, Ablasser A. The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol. 2021;21:548-69.
127. Monari C, Retini C, Casadevall A, et al. Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils. Eur J Immunol. 2003;33:1041-51.
128. Oliveira DL, Freire-de-Lima CG, Nosanchuk JD, Casadevall A, Rodrigues ML, Nimrichter L. Extracellular vesicles from Cryptococcus neoformans modulate macrophage functions. Infect Immun. 2010;78:1601-9.
129. Weiss ZF, DiCarlo JE, Basta DW, et al. Hidden in plain sight: urinary Cryptococcus neoformans missed by routine diagnostics in a patient with acute leukemia. Ann Clin Microbiol Antimicrob. 2022;21:49.
130. Wang Z, Zhang Q, Zhang H, Lu Y. Roles of alcohol dehydrogenase 1 in the biological activities of Candida albicans. Crit Rev Microbiol. 2025;51:484-98.
131. Rybak JM, Muñoz JF, Barker KS, et al. Mutations in TAC1B: a novel genetic determinant of clinical fluconazole resistance in Candida auris. mBio. 2020;11:e00365-20.
132. Li P, Seneviratne CJ, Alpi E, Vizcaino JA, Jin L. Delicate metabolic control and coordinated stress response critically determine antifungal tolerance of Candida albicans biofilm persisters. Antimicrobial Agents and Chemotherapy. 2015;59:6101-12.
133. Arita GS, Faria DR, Capoci IRG, Kioshima ES, Bonfim-Mendonça PS, Svidzinski TIE. Cell wall associated proteins involved in filamentation with impact on the virulence of Candida albicans. Microbiol Res. 2022;258:126996.
134. Sandini S, Stringaro A, Arancia S, et al. The MP65 gene is required for cell wall integrity, adherence to epithelial cells and biofilm formation in Candida albicans. BMC Microbiol. 2011;11:106.
135. Kulig K, Karnas E, Woznicka O, et al. Insight into the properties and immunoregulatory effect of extracellular vesicles produced by Candida glabrata, Candida parapsilosis, and Candida tropicalis biofilms. Front Cell Infect Microbiol. 2022;12:879237.
136. Zhao M, Zhang F, Zarnowski R, et al. Turbinmicin inhibits Candida biofilm growth by disrupting fungal vesicle-mediated trafficking. J Clin Invest. 2021;131:145123.
137. Zhang F, Zhao M, Braun DR, et al. A marine microbiome antifungal targets urgent-threat drug-resistant fungi. Science. 2020;370:974-8.
138. Toyofuku M, Cárcamo-Oyarce G, Yamamoto T, et al. Prophage-triggered membrane vesicle formation through peptidoglycan damage in. Nat Commun. 2017;8:481.
139. Andreoni F, Toyofuku M, Menzi C, et al. Antibiotics stimulate formation of vesicles in Staphylococcus aureus in both phage-dependent and -independent fashions and via different routes. Antimicrob Agents Chemother. 2019;63:e01439-18.
140. Allelein S, Medina-Perez P, Lopes ALH, et al. Potential and challenges of specifically isolating extracellular vesicles from heterogeneous populations. Sci Rep. 2021;11:11585.
141. Clos-Sansalvador M, Monguió-Tortajada M, Roura S, Franquesa M, Borràs FE. Commonly used methods for extracellular vesicles’ enrichment: implications in downstream analyses and use. Eur J Cell Biol. 2022;101:151227.
142. Musante L, Bontha SV, La Salvia S, et al. Rigorous characterization of urinary extracellular vesicles (uEVs) in the low centrifugation pellet - a neglected source for uEVs. Sci Rep. 2020;10:3701.
143. Erdbrügger U, Blijdorp CJ, Bijnsdorp IV, et al. Urinary extracellular vesicles: a position paper by the urine task force of the international society for extracellular vesicles. J Extracell Vesicles. 2021;10:e12093.
144. Correll VL, Otto JJ, Risi CM, et al. Optimization of small extracellular vesicle isolation from expressed prostatic secretions in urine for in-depth proteomic analysis. J Extracell Vesicles. 2022;11:e12184.
145. Brown CJ, Gaunitz S, Wang Z, et al. Glycoproteomic analysis of human urinary exosomes. Anal Chem. 2020;92:14357-65.
146. Teixeira-Marques A, Monteiro-Reis S, Montezuma D, et al. Improved recovery of urinary small extracellular vesicles by differential ultracentrifugation. Sci Rep. 2024;14:12267.
147. Dawson CS, Garcia-Ceron D, Rajapaksha H, Faou P, Bleackley MR, Anderson MA. Protein markers for Candida albicans EVs include claudin-like Sur7 family proteins. J Extracell Vesicles. 2020;9:1750810.
